MD2722B2 - Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis - Google Patents
Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosisInfo
- Publication number
- MD2722B2 MD2722B2 MDA20020265A MD20020265A MD2722B2 MD 2722 B2 MD2722 B2 MD 2722B2 MD A20020265 A MDA20020265 A MD A20020265A MD 20020265 A MD20020265 A MD 20020265A MD 2722 B2 MD2722 B2 MD 2722B2
- Authority
- MD
- Moldova
- Prior art keywords
- vitamin
- pharmaceutical composition
- magnesium
- osteoporosis
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, namely to a pharmaceutical composition that may be used for prophylaxis and treatment of osteoporosis.Summary of the invention consists in that the pharmaceutical composition contains calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, where to a dose of calcium of 150…1500 mg, preferably of 200…600 mg, may be taken 100…1000 IU, preferably 400…900 IU of vitamin D, or 20…500 mg, preferably 150…300 mg of magnesium, wherein the active substances containing calcium and magnesium are finely grounded so that at least 80% of particles have dimensions under 75 µm and, moreover, contain conventional adjuvants and pharmaceutically acceptable derivatives of starch, preferably diphosphate starch in a quantity of 5…40 wt%, preferably of 15…25 wt%; substances of vegetal origin able to form xerogels with the water, preferably carragheenan, in a quantity of 0,1…1,0 wt%, preferably of 0,2…0,6 wt%.The aforesaid composition represents a quick-soluble powder, which at the addition of liquids, after a short mixing, form a pudding resembling gellylike suspension, well-tolerated by patients.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK498-2000A SK284948B6 (en) | 2000-04-06 | 2000-04-06 | Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin D or mixture of calcium and magnesium in a new formulation |
PCT/SK2001/000004 WO2001076610A1 (en) | 2000-04-06 | 2001-03-15 | Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
MD20020265A MD20020265A (en) | 2003-05-31 |
MD2722B2 true MD2722B2 (en) | 2005-03-31 |
Family
ID=20435843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20020265A MD2722B2 (en) | 2000-04-06 | 2001-03-15 | Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1274447A1 (en) |
AU (1) | AU2001239668A1 (en) |
BG (1) | BG107227A (en) |
CZ (1) | CZ303069B6 (en) |
EE (1) | EE200200584A (en) |
MD (1) | MD2722B2 (en) |
PL (1) | PL357777A1 (en) |
RU (1) | RU2002130196A (en) |
SK (1) | SK284948B6 (en) |
WO (1) | WO2001076610A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067150B2 (en) * | 2002-04-16 | 2006-06-27 | Scepter Holdings, Inc. | Delivery systems for functional ingredients |
ATE516019T1 (en) | 2004-05-11 | 2011-07-15 | Egalet Ltd | SWELLABLE DOSAGE FORM WITH GELLAN GUMMIT |
UA95093C2 (en) | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Method for the preparation of calcium-containing compound |
RS52239B (en) * | 2009-03-26 | 2012-10-31 | Pulmatrix, Inc. | Pharmaceutical formaulations and methods for treating respiratory tract infections |
ES2625260T5 (en) | 2009-03-26 | 2020-07-29 | Pulmatrix Operating Co Inc | Dry powder formulations and methods for the treatment of lung diseases |
EP2448571B1 (en) | 2010-08-30 | 2013-06-12 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
CA2812414C (en) | 2010-09-29 | 2020-09-22 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
JP2015509788A (en) | 2012-02-29 | 2015-04-02 | パルマトリックス,インコーポレイテッド | Dry powder suitable for inhalation |
JP6473738B2 (en) | 2013-04-01 | 2019-02-20 | パルマトリックス,インコーポレイテッド | Tiotropium dry powder |
JO3456B1 (en) | 2015-05-13 | 2020-07-05 | H Lundbeck As | Vortioxetine pyroglutamate |
RU2726438C2 (en) * | 2018-11-14 | 2020-07-14 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) | Method for production of a dry high protein milk mixture for prevention of osteopenia in children and adolescents with gee's disease |
CN109453126A (en) * | 2018-12-07 | 2019-03-12 | 浙江核力欣健药业有限公司 | A kind of calcium carbonate D3Composition of chewable tablets and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
US5637313A (en) * | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
WO1999047122A1 (en) * | 1998-03-16 | 1999-09-23 | Smtm Group, Llc | Chewable calcium supplement and method for making it |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4650669A (en) * | 1985-07-30 | 1987-03-17 | Miles Laboratories, Inc. | Method to make effervescent calcium tablets and calcium tablets produced thereby |
CA1297035C (en) * | 1987-12-29 | 1992-03-10 | Warner-Lambert Canada Inc. | Chewable, non-gritty calcium citrate tablet |
US5296476A (en) * | 1989-09-08 | 1994-03-22 | Henderson Esther G | Skin care compositions |
-
2000
- 2000-04-06 SK SK498-2000A patent/SK284948B6/en not_active IP Right Cessation
-
2001
- 2001-03-15 AU AU2001239668A patent/AU2001239668A1/en not_active Abandoned
- 2001-03-15 CZ CZ20023292A patent/CZ303069B6/en not_active IP Right Cessation
- 2001-03-15 WO PCT/SK2001/000004 patent/WO2001076610A1/en not_active Application Discontinuation
- 2001-03-15 MD MDA20020265A patent/MD2722B2/en unknown
- 2001-03-15 EE EEP200200584A patent/EE200200584A/en unknown
- 2001-03-15 RU RU2002130196/15A patent/RU2002130196A/en unknown
- 2001-03-15 EP EP01914325A patent/EP1274447A1/en not_active Withdrawn
- 2001-03-15 PL PL01357777A patent/PL357777A1/en not_active Application Discontinuation
-
2002
- 2002-10-29 BG BG107227A patent/BG107227A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587399A (en) * | 1992-12-23 | 1996-12-24 | Abbott Laboratories | Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases |
US5637313A (en) * | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
WO1999047122A1 (en) * | 1998-03-16 | 1999-09-23 | Smtm Group, Llc | Chewable calcium supplement and method for making it |
Also Published As
Publication number | Publication date |
---|---|
EP1274447A1 (en) | 2003-01-15 |
MD20020265A (en) | 2003-05-31 |
EE200200584A (en) | 2004-04-15 |
PL357777A1 (en) | 2004-07-26 |
AU2001239668A1 (en) | 2001-10-23 |
CZ303069B6 (en) | 2012-03-21 |
RU2002130196A (en) | 2004-03-27 |
BG107227A (en) | 2003-05-30 |
SK284948B6 (en) | 2006-03-02 |
WO2001076610A1 (en) | 2001-10-18 |
SK4982000A3 (en) | 2001-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD2722B2 (en) | Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis | |
WO2001041770A3 (en) | Nanoparticulate eplerenone compositions | |
WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
WO1999059544A3 (en) | Orally disintegrable tablets | |
US3590117A (en) | Long-lasting troche containing guar gum | |
JP2010215611A (en) | Medicinal preparation containing loxoprofen | |
IE48879B1 (en) | An analgesic effervescent powder and process for its preparation | |
US3632778A (en) | Tablets containing l-dopa | |
ZA200301007B (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations. | |
US5922351A (en) | Lubricants for use in tabletting | |
HUP0004363A2 (en) | Solid pharmaceutical compositions containing miltefosine for use in the treatment of leishmaniasis | |
JP6580414B2 (en) | Herbal powder-containing tablets | |
WO2008079343A3 (en) | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients | |
JP2001097856A (en) | Antitussive | |
KR20010052819A (en) | Cyclophosphamide coated tablets | |
US2967131A (en) | Therapeutic composition | |
EP0305968A3 (en) | Compositions against protozoal diseases | |
WO2003061557A3 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
CA1119517A (en) | Oral formulations for human use | |
JP4899304B2 (en) | Solid preparation for internal use containing ambroxol hydrochloride | |
EP0272393A3 (en) | Pharmaceutical combination | |
NZ315632A (en) | Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water | |
UA79567C2 (en) | Orodispersible pharmaceutical composition of antithrombolic compound | |
GB2336999A (en) | High-dosage triclosan compositions | |
KR900701284A (en) | Finely divided cholestipol hydrochloride |